Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial

Posted on by

Lancet Infectious Diseases
Jul 2020 Volume 20 Number 7 p755-874, e148-e179
http://www.thelancet.com/journals/laninf/issue/current

 

Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Esper G Kallas, et al